[LXRX] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
06-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -2,920.70%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 322,073 63,209 90,335 83,337 130,014 22,854 2,222 129.10%
PBT 124,119 -120,548 -141,711 -141,429 -4,682 -100,364 -104,126 -
Tax -6,014 3,508 -12,661 4,511 5,995 -70 -833 39.00%
NP 130,133 -120,548 -129,050 -141,429 -4,682 -100,294 -104,126 -
Tax Rate 4.85% - - - - - - -
Total Cost 191,940 183,757 219,385 224,766 134,696 123,148 106,348 10.33%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 40.40 -190.71 -142.86 -169.71 -3.60 -438.85 -4,686.14 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS 1.23 -1.14 -1.23 -1.36 -0.05 -1.31 -1.42 -
EPS Diluted 1.11 -1.14 -1.23 -1.36 -0.05 -1.31 -1.42 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.